Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Santreva™-ATK Endovascular Revasculariztion Catheter

K-Number: K252315 · 2025-09-22

Decision Date2025-09-22
Product CodePDU
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Santreva™-ATK Endovascular Revasculariztion Catheter is a medical device manufactured by AngioSafe, Inc.. It received FDA 510(k) clearance on 2025-09-22 under approval number K252315. The device is classified under product code PDU. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Santreva™-ATK Endovascular Revasculariztion Catheter?

Santreva™-ATK Endovascular Revasculariztion Catheter is a medical device that received FDA 510(k) clearance on 2025-09-22. It is manufactured by AngioSafe, Inc.. The 510(k) number is K252315.

When was Santreva™-ATK Endovascular Revasculariztion Catheter approved by the FDA?

Santreva™-ATK Endovascular Revasculariztion Catheter received FDA 510(k) clearance on 2025-09-22, under approval number K252315.

What company makes Santreva™-ATK Endovascular Revasculariztion Catheter?

Santreva™-ATK Endovascular Revasculariztion Catheter is manufactured by AngioSafe, Inc..

What is the FDA product code for Santreva™-ATK Endovascular Revasculariztion Catheter?

The FDA product code for Santreva™-ATK Endovascular Revasculariztion Catheter is PDU.

Related Clinical Trials

Related Devices (Code: PDU)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.